227 related articles for article (PubMed ID: 28125710)
21. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma.
Dillon MF; Hill AD; Fleming FJ; O'Doherty A; Quinn CM; McDermott EW; O'Higgins N
Am J Surg; 2006 Feb; 191(2):201-5. PubMed ID: 16442946
[TBL] [Abstract][Full Text] [Related]
22. [Krükenberg tumors of breast origin. 10 cases].
Le Bouëdec G; de Latour M; Levrel O; Dauplat J
Presse Med; 1997 Mar; 26(10):454-7. PubMed ID: 9137366
[TBL] [Abstract][Full Text] [Related]
23. Deliveries following fertility preservation by ovarian tissue cryopreservation without autotransplantation-what should be expected?
Lantsberg D; Farhi A; Zaslavsky-Paltiel I; Silverman BG; Lerner-Geva L; Orvieto R
J Assist Reprod Genet; 2019 Feb; 36(2):335-340. PubMed ID: 30374733
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
25. Patterns and determinants of surgical management of screen detected breast cancer in the South-East Netherlands.
Liebregts ME; van Riet YE; Nieuwenhuijzen GA; Rutten HJ; Duijm LE; Voogd AC
Breast; 2013 Oct; 22(5):713-7. PubMed ID: 23352567
[TBL] [Abstract][Full Text] [Related]
26. Ovarian metastases from breast cancer: report of 29 cases.
Bigorie V; Morice P; Duvillard P; Antoine M; Cortez A; Flejou JF; Uzan S; Darai E; Barranger E
Cancer; 2010 Feb; 116(4):799-804. PubMed ID: 20041486
[TBL] [Abstract][Full Text] [Related]
27. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis.
Sun C; Chen G; Yang Z; Jiang J; Yang X; Li N; Zhou B; Zhu T; Wei J; Weng D; Ma D; Wang C; Kong B
Fertil Steril; 2013 Sep; 100(3):782-7. PubMed ID: 23830105
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible?
Elias D; Duchalais E; David A; Dartigues P; Duvillard P; Poirot C; Goéré D
Eur J Surg Oncol; 2013 Jul; 39(7):748-53. PubMed ID: 23523317
[TBL] [Abstract][Full Text] [Related]
29. Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact?
Soucy G; Bélanger J; Leblanc G; Sideris L; Drolet P; Mitchell A; Leclerc YE; Dufresne MP; Beaudet J; Dubé P
J Am Coll Surg; 2008 Jun; 206(6):1116-21. PubMed ID: 18501808
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian metastasis of extragenital tumors at the Zurich University Gynecologic Clinic 1978-1990].
Perucchini D; Caduff R; Schär G; Fink D; Köchli OR
Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):351-6. PubMed ID: 8964449
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.
Lee SJ; Lee J; Lim HY; Kang WK; Choi CH; Lee JW; Kim TJ; Kim BG; Bae DS; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Jul; 66(2):229-35. PubMed ID: 19820936
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Metastases from Breast Cancer: A Series of 28 Cases.
Pimentel C; Becquet M; Lavoue V; Henno S; Leveque J; Ouldamer L
Anticancer Res; 2016 Aug; 36(8):4195-200. PubMed ID: 27466531
[TBL] [Abstract][Full Text] [Related]
33. The Value of Ipsilateral Breast Tumor Recurrence as a Quality Indicator: Hospital Variation in the Netherlands.
van der Heiden-van der Loo M; Siesling S; Wouters MW; van Dalen T; Rutgers EJ; Peeters PH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S522-8. PubMed ID: 25986872
[TBL] [Abstract][Full Text] [Related]
34. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
35. Outcome of ovarian preservation during surgical treatment for endometrial cancer: A Taiwanese Gynecologic Oncology Group study.
Lau HY; Chen MY; Ke YM; Chen JR; Chen IH; Liou WS; Fu HC; Chang CC; Hsu KF; Wang KL
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):532-6. PubMed ID: 26522105
[TBL] [Abstract][Full Text] [Related]
36. Ovarian disease in women with breast cancer.
Curtin JP; Barakat RR; Hoskins WJ
Obstet Gynecol; 1994 Sep; 84(3):449-52. PubMed ID: 8058246
[TBL] [Abstract][Full Text] [Related]
37. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
[TBL] [Abstract][Full Text] [Related]
38. Surgery in metastatic breast cancer: patients with a favorable profile seem to have the most benefit from surgery.
Rashaan ZM; Bastiaannet E; Portielje JE; van de Water W; van der Velde S; Ernst MF; van de Velde CJ; Liefers GJ
Eur J Surg Oncol; 2012 Jan; 38(1):52-6. PubMed ID: 22032912
[TBL] [Abstract][Full Text] [Related]
39. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
40. Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue.
Peters IT; Hilders CG; Sier CF; Vahrmeijer AL; Smit VT; Baptist Trimbos J; Kuppen PJ
Arch Gynecol Obstet; 2016 Aug; 294(2):385-93. PubMed ID: 26946151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]